ENTRY       D11242                      Drug
NAME        Trevogrumab (USAN/INN)
FORMULA     C6374H9884N1696O2018S46
EXACT_MASS  143947.0091
MOL_WEIGHT  144035.8232
SEQUENCE    (Heavy chain)
            EVQVLESGGD LVQPGGSLRL SCAASGFTFS AYAMTWVRQA PGKGLEWVSA ISGSGGSAYY
            ADSVKGRFTI SRDNSKNTVY LQMNSLRAED TAVYYCAKDG AWKMSGLDVW GQGTTVIVSS
            ASTKGPSVFP LAPCSRSTSE STAALGCLVK DYFPEPVTVS WNSGALTSGV HTFPAVLQSS
            GLYSLSSVVT VPSSSLGTKT YTCNVDHKPS NTKVDKRVES KYGPPCPPCP APEFLGGPSV
            FLFPPKPKDT LMISRTPEVT CVVVDVSQED PEVQFNWYVD GVEVHNAKTK PREEQFNSTY
            RVVSVLTVLH QDWLNGKEYK CKVSNKGLPS SIEKTISKAK GQPREPQVYT LPPSQEEMTK
            NQVSLTCLVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS DGSFFLYSRL TVDKSRWQEG
            NVFSCSVMHE ALHNHYTQKS LSLSLGK
            (Light chain)
            DIQMTQSPAS LSASVGDRVT ITCRASQDIS DYLAWYQQKP GKIPRLLIYT TSTLQSGVPS
            RFRGSGSGTD FTLTISSLQP EDVATYYCQK YDSAPLTFGG GTKVEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide bridge: H22-H96, H134-L214, H147-H203, H226-H'226, H229-H'229, H261-H321, H367-H425, H'22-H'96, H'134-L'214, H'147-H'203, H'261-H'321, H'367-H'425, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  TYPE      Peptide
EFFICACY    Myostatin inhibitor
  TYPE      Monoclonal antibody
COMMENT     Treatment of muscle atrophy due to orthopedic disuse and sarcopenia
TARGET      MSTN [HSA:2660] [KO:K05497]
  PATHWAY   hsa04060(2660)  Cytokine-cytokine receptor interaction
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Transforming growth factors (RSTK-binding)
                MSTN
                 D11242  Trevogrumab (USAN/INN)
DBLINKS     CAS: 1429201-24-0
            PubChem: 384585220
///
